Bradmer Pharmaceuticals Inc. (TSE:GLX) Given Average Rating of “Buy” by Analysts

Bradmer Pharmaceuticals Inc. (TSE:GLX) has earned a consensus recommendation of “Buy” from the eight brokerages that are covering the firm, MarketBeat reports. Two analysts have rated the stock with a hold rating, one has given a buy rating and five have issued a strong buy rating on the company.

Several brokerages have commented on GLX. Citigroup upgraded shares of Bradmer Pharmaceuticals to a “hold” rating in a report on Tuesday, February 24th. ATB Cormark Capital Markets cut shares of Bradmer Pharmaceuticals from a “strong-buy” rating to a “moderate buy” rating in a report on Thursday, February 5th. Finally, Citizens Jmp raised shares of Bradmer Pharmaceuticals to a “strong-buy” rating in a research report on Tuesday, December 9th.

Bradmer Pharmaceuticals Price Performance